Search clinical trials for: tacrolimus OD, mycophenolic acid, prednisolone

Total 1391 results

Novartis

Completed

Extension Study of the Safety and Efficacy of Enteric-coated Mycophenolate Sodium in Kidney Transplant Recipients

Renal Transplantation
University Health Network, Toronto

Unknown

Gastrointestinal Tolerability of MMF vs EC-MPS in Maintenance Transplant Patients Treated With Calcineurin Inhibitors (MOTOR-MPA)

Organ Transplantation

Canada
First Affiliated Hospital Xi'an Jiaotong University

Recruiting

Clinical Study of MMF in Treatment of IIM-ILD and Its Effect on Peripheral Blood Treg Cells

Idiopathic Inflammatory Myopathy | Interstitial Lung Disease

China
Novartis Pharmaceuticals

Completed

Measurement of Patient Reported Outcomes in Renal Transplant Patients With and Without Gastrointestinal (GI) Symptoms (PROGIS)

Kidney Maintenance Transplant
Seoul National University Hospital
Chong Kun Dang Pharmaceutical

Completed

Mycophenolate Mofetil in Pediatric Steroid Dependent Nephrotic Syndrome

Nephrotic Syndrome

Korea, Republic of
Novartis

Completed

Extension Study of Enteric-coated Mycophenolate Sodium With Short-term or no Steroid Use Compared With Enteric-coated Mycophenolate Sodium With Standard Steroid Therapy in de Novo Kidney Recipients

Renal Transplantation
University of Michigan
Hoffmann-La Roche

Completed

Pharmacokinetics of Mmf and Valganciclovir

Kidney Transplant Recipient | Heart Transplant Recipient

United States
Novartis

Completed

Extension Study to Assess Tolerability and Safety of Enteric-coated Mycophenolate Sodium in Renal Transplant Recipients Who Received Mycophenolate Mofetil

Renal Transplantation
Novartis

Completed

Extension Study on the Safety and Efficacy of Enteric-coated Mycophenolate Sodium in Kidney Transplant Recipients

Renal Transplantation
Novartis Pharmaceuticals

Completed

Freedom Study: Myfortic in Kidney Transplant Patients

Kidney Transplantation

Spain, United Kingdom, Taiwan, Australia, United States, Canada, Singapore, Malaysia, Germany, Argentina, Brazil, Italy, New Zealand
Mesoblast, Inc.

Completed

Safety and Efficacy Study of Adult Human Mesenchymal Stem Cells to Treat Acute Graft Versus Host Disease (GVHD)

Graft Vs Host Disease

United States
Ain Shams University
National Hepatology & Tropical Medicine Research Institute

Completed

Tacrolimus Versus Hydrocortisone in Atopic Dermatitis

Dermatitis | Atopic

Egypt
Novartis

Completed

Efficacy and Safety of Enteric-coated Mycophenolate Sodium and Cyclosporine in Combination With and Without Steroids, in Adult Renal Transplant Recipients

Renal Transplantation

France
University of California, San Francisco
National Cancer Institute (NCI)

Completed

Donor Umbilical Cord Blood Transplant in Treating Patients With Advanced Hematologic Cancer

Lymphoma | Myelodysplastic Syndromes | Leukemia | Multiple Myeloma and Plasma Cell Neoplasm

United States
National Institute of Allergy and Infectious Diseases...
Johns Hopkins University; PPD

Active, not recruiting

COVID Protection After Transplant-Immunosuppression Reduction (CPAT-ISR)

Liver Transplant Recipients | Kidney Transplant Recipients

United States
National Institute of Allergy and Infectious Diseases...
Clinical Trials in Organ Transplantation

Terminated

Optimization of NULOJIX® Usage As A Means of Avoiding CNI and Steroids in Renal Transplantation

Kidney Transplantation | Renal Transplantation

United States
Novartis Pharmaceuticals

Completed

SOCRATES: Steroid or Cyclosporine Removal After Transplantation Using Everolimus

Renal Transplanted Recipients

Australia
University of Nebraska
National Cancer Institute (NCI)

Completed

Busulfan, Cyclophosphamide, & Antithymocyte Globulin Followed by Stem Cell Transplant in Treating Hematologic Cancer

Lymphoma | Myelodysplastic Syndromes | Leukemia | Multiple Myeloma and Plasma Cell Neoplasm | Myelodysplastic/Myeloproliferative Diseases | Graft Versus Host Disease | Secondary Myelofibrosis

United States
UniQure Biopharma B.V.
Chiesi Farmaceutici S.p.A.

Withdrawn

Alipogene Tiparvovec for the Treatment of LPLD Patients

LPL Deficiency

Canada, United States
Genovate Biotechnology Co., Ltd.,

Completed

Mycophenolate Mofetil Versus Azathioprine for Maintenance Therapy of Lupus Nephritis

Lupus Nephritis
First Affiliated Hospital of Guangxi Medical University
Peking University People's Hospital; Ruijin Hospital; The Affiliated Hospital... and other collaborators

Recruiting

Hematopoietic Stem Cell Transplantation for Patients With Thalassemia Major: A Multicenter, Prospective Clinical Study

Thalassemia Major

China
National Institute on Drug Abuse (NIDA)
Johns Hopkins University

Unknown

Randomized Study of Interventions to Enhance Adherence to Isoniazid Prevention Therapy for Tuberculosis in Injection Drug Users

Tuberculosis
Novartis

Completed

Measurement of Patient Reported Gastrointestinal (GI) and Health-related Quality of Life (HRQL) Outcomes in Renal Transplant Recipients (MyLife)

Renal Transplantation | Gastrointestinal Problems

Germany, Switzerland
Postgraduate Institute of Medical Education and...

Completed

Study to Compare the Efficacy of Mycophenolate Mofetil in Systemic Sclerosis Related Early Interstitial Lung Disease (MYILD)

Systemic Sclerosis | Interstitial Lung Disease | Scleroderma

India
Novartis

Completed

Efficacy and Safety of Enteric-coated Mycophenolate Sodium (EC-MPS) in de Novo Kidney Transplant Recipients

Renal Transplantation

Switzerland
Irmandade Santa Casa de Misericórdia de Porto Alegre
Novartis

Completed

A Prospective Study to Investigate Mycophenolic Acid (MPA) Exposure Through Area Under the Curve (AUC) in Renal Transplants Recipients Treated With Mycophenolate Mofetil (MMF) and After Conversion to Mycophenolate Sodium (EC-MPS) (AUC-MPA)

Renal Transplantation

Brazil
Chong Kun Dang Pharmaceutical

Unknown

The Study to Evaluate Efficacy and Safety of MY-REPT Capsule in Primary, Liver Transplantation Recipients (MYLT1)

Evidence of Liver Transplantation

Korea, Republic of
Novartis

Completed

Extension Study on the Efficacy and Safety of Enteric-coated Mycophenolate Sodium Administered in de Novo Kidney Transplant Patients

De Novo Kidney Transplantation
Novartis

Completed

Safety and Tolerability of Enteric-Coated Mycophenolate Sodium (EC-MPS) in Renal Transplant Patients With GI Intolerance

Renal Transplantation

United States
Thomas Jefferson University

Recruiting

Reduced-Intensity Conditioning for the Prevention of Treatment-Related Mortality in Patients Who Undergo a Hematopoietic Stem Cell Transplant

Hematopoietic and Lymphoid Cell Neoplasm | Acute Myeloid Leukemia | Myelodysplastic Syndromes | Myeloid Leukemia | Polycythemia Vera | Essential Thrombocythemia | Hodgkin Lymphoma | Myelofibrosis | Chronic Myelomonocytic Leukemia | Acute Lymphoblastic Leukemia | Chronic Lymphocytic Leukemia | Non-Hodgkin Lymphoma and other conditions

United States
Sidney Kimmel Cancer Center at Thomas Jefferson...

Completed

Donor Stem Cell Transplant in Treating Patients With High-Risk Hematologic Malignancies

Hematologic Malignancy

United States
Novartis Pharmaceuticals

Completed

12 Month Athena Study: Everolimus vs. Standard Regimen in de Novo Kidney Transplant Patients (ATHENA)

Kidney Transplantation | Renal Transplantation

Germany, France
MedImmune LLC

Completed

MEDI-522 in the Treatment of Patients With Metastatic Androgen-Independent Prostate Cancer

Prostate Cancer

United States, Belgium, Israel, Russian Federation, Canada, Hungary, Poland
Assiut University

Unknown

Topical Immuonosuppressant Drugs in Spring Catarrh

Vernal Keratoconjunctivitis

Egypt
Memorial Sloan Kettering Cancer Center

Completed

Haploidentical (Half-matched) Related Donor Stem Cell Transplantation Using Killer Immunoglobulin-like Receptors in Addition to Normal Selection Factors to Determine the Best Donor

Hematologic Malignancy

United States
Northwell Health

Completed

HSCT For Patients With High Risk Hemoglobinopathies Using Reduced Intensity

Sickle Cell Disease | Beta Thalassemia-Major

United States
Sidney Kimmel Cancer Center at Thomas Jefferson...

Completed

Bone Marrow Transplantation of Patients in Remission Using Partially Matched Relative Donor

Lymphoma | Acute Myeloid Leukemia | Myelodysplastic Syndromes | Chronic Lymphocytic Leukemia | Chronic Myeloid Leukemia | Acute Lymphocytic Leukemia | Aplastic Anemia | Hodgkin's Disease | Biphenotypic Leukemia | Plasma Cell Neoplasms

United States
National Institute of Allergy and Infectious Diseases...
Clinical Islet Transplantation Consortium

Completed

LEA29Y (Belatacept) Emory Edmonton Protocol (LEEP)

Type 1 Diabetes Mellitus

United States, Canada
Third Affiliated Hospital, Sun Yat-Sen University
Beijing Friendship Hospital; Beijing YouAn Hospital; RenJi Hospital; Huashan Hospital and other collaborators

Recruiting

Long-term Benefit of MPA in Liver Transplantation

Liver Transplant Rejection | Immunosuppressant Adverse Reaction

China
Nanjing University School of Medicine

Completed

Mycophenolate Mofetil Versus Intravenous Cyclophosphamide Pulses in the Treatment of Crescentic IgA Nephropathy

IGA Nephropathy

China
Hoffmann-La Roche
Aspreva Pharmaceuticals

Completed

A Continuation Study to Assess the Effect of CellCept in Patients With Myasthenia Gravis.

Myasthenia Gravis Generalised

France, Ukraine, Germany, United States, Italy, United Kingdom, Former Serbia and Montenegro
University of Rochester
Batten Disease Support and Research Assocation (BDSRA)

Completed

Cellcept for Treatment of Juvenile Neuronal Ceroid Lipofuscinosis (JUMP)

Juvenile Neuronal Ceroid Lipofuscinosis

United States
Nanjing University School of Medicine

Completed

Mycophenolate Mofetil (MMF) Versus Intravenous CTX Pulses in the Treatment of Adult Severe HSPN

Nephritis | Henoch-Schoenlein Purpura

China
Rabin Medical Center

Unknown

CellCept® Dose Adjustment Versus Fixed Dose (Standard Care) in Renal Transplant Recipients (MMF)

Renal Transplant

Israel
Chong Kun Dang Pharmaceutical

Completed

Study to Evaluate the Pharmacokinetic Characteristics of CKD-4101 (Mycophenolate Mofetil) Tablet

Healthy

Korea, Republic of
University of Wisconsin, Madison

Terminated

Campath, Rituximab, and Myfortic With Short-Course Calcineurin Inhibitor Therapy in Renal Transplanation

Renal Transplantation | Acute Rejection

United States
Vastra Gotaland Region
Oslo University Hospital; Helsinki University Central Hospital; Skane University... and other collaborators

Active, not recruiting

Clinical Study Evaluating Two Treatment Protocols for Immunosuppressive Drugs. Looking at 3-year Incidence of CLAD. (ScanCLAD)

Lung Transplantation | Allografts

Norway, Sweden, Finland, Denmark
National Institute of Allergy and Infectious Diseases...
Cooperative Clinical Trials in Pediatric Transplantation

Completed

Safety in Immunomodulatory Functions of Alemtuzumab (Campath) in Pediatric Kidney Transplantation Recipients

Kidney Failure, Chronic | Kidney Transplantation | Immunosuppression

United States
Hoffmann-La Roche

Completed

A Study of CellCept (Mycophenolate Mofetil) Combined With Calcineurin Inhibitors in Liver Transplant Patients.

Liver Transplantation

China
Peking University First Hospital
First Affiliated Hospital, Sun Yat-Sen University; Tongji Hospital; Guangzhou... and other collaborators

Recruiting

Registry of IgA Nephropathy in Chinese Children (RACC)

IgA Nephropathy | Immunosuppressive Treatment | Proteinuria in Nephrotic Range

China

Search clinical trials for: tacrolimus OD, mycophenolic acid, prednisolone

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Uzbekistan

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations